US Patent 9481892 Controlled activation of non-LTR retrotransposons in mammals
All edits
Edits on 5 Dec, 2023
Golden AI
Edits made to:
Article (+305 characters)
Article
Patent abstract
The invention relates to nucleic acids, vector constructs which allow the controlled activation and inhibition of retrotransposition of non-LTR retrotransposons. The methods of this invention are useful for preparing said nucleic acids and vector constructs and introducing them into cells.
Edits on 29 Sep, 2023
Golden AI
Edits made to:
Infobox (+2 properties)
Infobox
Patent Inventor Names
Gerald Schumann0
Liliana Elisabeth Layer0
Edits on 22 Jul, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 14 Jun, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 20 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 09481892 Controlled activation of non-LTR retrotransposons in mammals US Patent 9481892 Controlled activation of non-LTR retrotransposons in mammals
Infobox
Patent Number
094818920
Patent Number
94818920
Edits on 26 Sep, 2022
Golden AI
Infobox
Is a
Patent Jurisdiction
Patent Number
094818920
Date of Patent
November 1, 2016
0Patent Application Number
127409430
Date Filed
October 30, 2008
0Official Website
Patent Primary Examiner
Edits on 6 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 9 Jan, 2022
Golden AI
Edits made to:
Infobox (+7 properties)
US Patent 09481892 Controlled activation of non-LTR retrotransposons in mammals
Infobox
Is a
Patent jurisdiction
Patent number
09481892
Date of patent
November 1, 2016
Patent application number
12740943
Date Filed
October 30, 2008
Patent primary examiner
Find more entities like US Patent 9481892 Controlled activation of non-LTR retrotransposons in mammals
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.